Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) has filed its Monthly Return for the period ended 30 June 2026 with Hong Kong Exchanges and Clearing Limited, confirming a stable capital structure during the month.

Authorised and Issued Share Capital • Authorised share capital remained unchanged at 1.00 billion ordinary shares with a par value of USD 0.05 each, equivalent to USD 50.00 million. • Issued share count stood at 557.08 million ordinary shares, identical to the previous month. The company continues to hold zero treasury shares, leaving total issued shares unaffected.

Public Float Compliance • The issuer confirmed compliance with the Main Board’s minimum public-float threshold of 25% as at 30 June 2026.

Share Option Scheme Update • Under the share option scheme adopted on 4 December 2020 and amended on 26 June 2026, 47.28 million options were outstanding at month-end, unchanged from May. • The scheme’s mandate limit has been refreshed to 55.71 million shares, representing 10% of the company’s total issued share capital. • No options were exercised during June, and no funds were raised from option exercises.

Conclusion For June 2026, RAILY AESMED recorded no movements in authorised capital, issued shares, or treasury shares, underscoring a steady equity base while maintaining regulatory public-float requirements. The refreshed option mandate provides capacity for future incentive grants without immediate dilution to existing shareholders.